The Competition and Markets Authority found that UnitedHealth's £1.2 billion acquisition of EMIS could reduce competition in the healthcare sector, potentially worsening outcomes for the NHS, patients, and UK taxpayers.
The Competition and Markets Authority found that UnitedHealth's £1.2 billion acquisition of EMIS could reduce competition in the healthcare sector, potentially worsening outcomes for the NHS, patients, and UK taxpayers.
The Competition and Markets Authority found that UnitedHealth's £1.2 billion acquisition of EMIS could reduce competition in the healthcare sector, potentially worsening outcomes for the NHS, patients, and UK taxpayers.